Literature DB >> 1739326

Streptococcus associated toxic shock.

C Torres-Martínez1, D Mehta, A Butt, M Levin.   

Abstract

In the past few years, there appears to have been a change in the spectrum of disease caused by group A beta-haemolytic streptococcus (GABHS), and a toxic shock-like syndrome caused by this organism has recently been described in adults. We report four children with an acute illness characterised by rapid progression of shock, erythematous rash, multisystem organ involvement, electrolyte derangements, and desquamation who fulfil the previously established diagnostic criteria for toxic shock syndrome. Three of the children had extensive cutaneous and soft tissue infection and the fourth had peritonitis. All four developed bacteraemia. Treatment included aggressive cardiovascular resuscitation and antibiotic therapy. Although no patient died, they suffered multiple and severe complications requiring prolonged treatment and hospitalisation. Streptococcal toxic shock syndrome is a separate and clearly defined entity occurring in previously healthy children.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739326      PMCID: PMC1793551          DOI: 10.1136/adc.67.1.126

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  31 in total

1.  Group A beta-hemolytic streptococcal toxic shock-like syndrome.

Authors:  J Begovac; E Marton; M Lisić; I Beus; D Bozinović; N Kuzmanović
Journal:  Pediatr Infect Dis J       Date:  1990-05       Impact factor: 2.129

2.  Group-A streptococcal infection in the newborn.

Authors:  J B Coulter; C R Buchannon; A Vellodi; C A Hart; J A Sills
Journal:  Lancet       Date:  1984-08-11       Impact factor: 79.321

3.  Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome.

Authors:  J K Todd; A Franco-Buff; D W Lawellin; M L Vasil
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

4.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

5.  Infective endocarditis in infants and children during the past 10 years: a decade of change.

Authors:  G F Van Hare; G Ben-Shachar; J Liebman; B Boxerbaum; T A Riemenschneider
Journal:  Am Heart J       Date:  1984-06       Impact factor: 4.749

6.  Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.

Authors:  K N Shands; G P Schmid; B B Dan; D Blum; R J Guidotti; N T Hargrett; R L Anderson; D L Hill; C V Broome; J D Band; D W Fraser
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

7.  Toxic-shock syndrome associated with phage-group-I Staphylococci.

Authors:  J Todd; M Fishaut; F Kapral; T Welch
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

8.  Group A streptococcal meningitis.

Authors:  D J Murphy
Journal:  Pediatrics       Date:  1983-01       Impact factor: 7.124

9.  Parapneumonic pleural effusion and empyema in children. Review of a 19-year experience, 1962-1980.

Authors:  T Chonmaitree; K R Powell
Journal:  Clin Pediatr (Phila)       Date:  1983-06       Impact factor: 1.168

10.  Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens.

Authors:  Y W Choi; A Herman; D DiGiusto; T Wade; P Marrack; J Kappler
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

View more
  13 in total

1.  Toxic shock-like syndrome due to Streptococcus pyogenes.

Authors:  J Eason; W Lenney; I Lewis
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

Review 2.  Neonatal erythroderma: differential diagnosis and management of the "red baby".

Authors:  P H Hoeger; J I Harper
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

3.  Potentially lethal bacterial infection associated with varicella zoster virus.

Authors:  A J Pollard; A Isaacs; E G Hermione Lyall; N Curtis; K Lee; S Walters; M Levin
Journal:  BMJ       Date:  1996-08-03

Review 4.  Toxic shock syndrome in children: epidemiology, pathogenesis, and management.

Authors:  Yu-Yu Chuang; Yhu-Chering Huang; Tzou-Yien Lin
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 5.  Streptococcal toxic shock syndrome in a postpartum woman. Case report and review of the literature.

Authors:  C Jorup-Rönström; M Hofling; C Lundberg; S Holm
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

6.  Sudden death associated with group A streptococcal infection in an 8-year-old girl with undiagnosed hypertrophic cardiomyopathy.

Authors:  R Bragonier; P Oades
Journal:  Postgrad Med J       Date:  1998-11       Impact factor: 2.401

7.  Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease.

Authors:  T Yoshioka; T Matsutani; S Iwagami; T Toyosaki-Maeda; T Yutsudo; Y Tsuruta; H Suzuki; S Uemura; T Takeuchi; M Koike; R Suzuki
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

8.  Streptococcal toxic shock-like syndrome: evidence of superantigen activity and its effects on T lymphocyte subsets in vivo.

Authors:  C Michie; A Scott; J Cheesbrough; P Beverley; G Pasvol
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

9.  Evidence for a superantigen mediated process in Kawasaki disease.

Authors:  N Curtis; R Zheng; J R Lamb; M Levin
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

Review 10.  Syndromes with renal failure and shock.

Authors:  M Levin
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.